GL1X · GenesisL1 explorer

Research workbench

Design and biological evaluation of novel, balanced dual PPARA/G agonists

Analyse Design and biological evaluation of novel, balanced dual PPARA/G agonists in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
3FEI
Type
protein
Length
254 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Peroxisome proliferator-activated receptor alpha; Peptide motif 5 of nuclear receptor…
UniProt
Q07869, Q15788
Ligands
CTM
Pockets
2 · best druggability 0.80

Structure

x-ray diffraction · 2 distinct chains · 68% helix, 5% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
APeroxisome proliferator-activated receptor alphaprotein24668% helix, 5% strandQ07869
ZPeptide motif 5 of nuclear receptor coactivator 1protein875% helix, 0% strandQ15788

Ligands and binding sites

  • CTM · (2S)-3-(4-{[2-(4-chlorophenyl)-1,3-thiazol-4-yl]methoxy}-2-methylphenyl)-2-ethoxypropanoic acid · ligand · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

2 pockets found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
13890.800.8949CTM
21050.440.7821empty

Interfaces

1 interface between chains.

  • A–Z · 587 Ų buried · 7 hydrogen bonds · protein-protein

Compared structures

  • 3FEI · Design and biological evaluation of novel, balanced dual PPARa/g agonists · the same entry in another collection · chain A against A, TM-score 1.00
  • Q07869 · AlphaFold monomer V2.0 prediction for peroxisome proliferator- activated receptor alpha… · a predicted model of the same protein · chain A against A, TM-score 0.99

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.